What Happened?
New York, NY-based Immune-Pharmaceuticals Appointed Daniel Teper as Chief Executive Officer
Date of management change: September 15, 2011
New York, NY-based Immune-Pharmaceuticals Appointed Daniel Teper as Chief Executive Officer
Immune Pharmaceuticals is developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases.
Daniel Teper is Chief Executive Officer at Immune Pharmaceuticals. Previously, Daniel held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Boards Fernandez, Diorio Ann, Russo Amelia, Swafford Joshua, Maday David, Smyczek Monika, Reyes Ricardo, Garrison Veronica, Brown Damone, Glauser Karen, Runyan Paul
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.